Completed
Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)
NCT00124189
- Conditions
- Chronic Disease, Chronic Lymphoproliferative Diseases, Disease Attributes, +17 more
- Locations
-
- Rocky Mountain Cancer Center Denver, Colorado, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- Roswell Park Cancer Center Buffalo, New York, United States
- Long Island Jewish Medical Center New Hyde Park, New York, United States